|
EM2
- Modern Management of External Anogenital Warts
Chairs: A.
Ferenczy and J. Monsonego
| Contributors: |
A.
Ferenczy, Canada
S Tyring, USA |
|
Epidemiology
and Natural History
S. Tyring
- Almost all cases
of genital warts in adults are transmitted sexually.
- The prevalence
of genital warts in the general population is unknown.
- Current epidemiology
estimates that ano-genital warts afflict about 1% of the sexually active
population and the incidence is in the order of 1/1000 sexually active
individuals per year.
Clinical presentation
of ano-genital warts
S. Tyring
- Acuminate warts
are multi-form, multi-focal and multicentric and most are caused by
lowrisk HPV types 6, 11.
- Acuminate warts
are clinically typical and do not require routine biopsy. For all other
lesions, histologic examination is required.
- Differential diagnoses
include VIN and dermatoses.
- The acetic acid
test is not specific it may be valuable for identifying and delineating
subclinical lesions associated with EGWs.
External Genital
Warts: Management
A. Ferenczy
- Condylomata acuminata
constitute a risk marker for external ano-genital cancer particularly
in the immuno-suppressed and to a lesser degree, for cervical cancer.
- Conventional treatment
of genital condylomata acuminata has been disappointing. Analysis of
available data relating to cytotoxic or destructive therapy has shown
that persistence and recurrences occur in about 50% of the cases.
- The 2 main reasons
for this are the treatments may be incomplete and do not focus on the
etiologic virus, i.e., HPV 6/11.
- Both basic research
and clinical practice indicate that immunity, and in particular local
cellular immunity, is an essential feature of the development, persistence
and regression of this disease.
- The recent introduction
of topical immune system modifiers is considered to be a significant
progress in our efforts to provide improved topical therapy for EGWs.
- The best therapeutic
approach is based on a mutual decision made by the patient and her health-care
provider of a choice of home versus provider-administered treatment
and long-term follow-up of patients with EGWs.
External Genital
Warts: Screening and Counselling
A. Ferenczy
- No practical screening
tests are available for EGWs and screening is not recommended.
- Contact-tracing:
i.e., partner(s) of patients with EGWs may be examined and this is an
opportunity for patient education and counselling.
- Patients should
be counselled in light of today's knowledge of transmission, genital
cancer-risk, therapy and outcome.
- Issues of life-style
modification including mutual monogamy and long-term follow-up should
be stressed.
- Cesarean section
to prevent juvenile onset of recurrent respiratory papillomavirus in
pregnant patients with EGWs is not recommended at present. Cesarean
section is appropriate in cases of extreme ano-genital condylomatosis
at term.
|